Logo image of DEX.MI

DEXELANCE SPA (DEX.MI) Stock Fundamental Analysis

BIT:DEX - Euronext Milan - IT0005543480 - Common Stock - Currency: EUR

6.72  +0.1 (+1.51%)

Fundamental Rating

5

Taking everything into account, DEX scores 5 out of 10 in our fundamental rating. DEX was compared to 34 industry peers in the Household Durables industry. Both the profitability and the financial health of DEX get a neutral evaluation. Nothing too spectacular is happening here. DEX may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

DEX had positive earnings in the past year.
In the past year DEX had a positive cash flow from operations.
DEX had positive earnings in 4 of the past 5 years.
In the past 5 years DEX always reported a positive cash flow from operatings.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

With a decent Return On Assets value of 4.04%, DEX is doing good in the industry, outperforming 71.43% of the companies in the same industry.
DEX's Return On Equity of 10.92% is fine compared to the rest of the industry. DEX outperforms 65.71% of its industry peers.
The Return On Invested Capital of DEX (7.68%) is better than 68.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DEX is significantly below the industry average of 16.06%.
Industry RankSector Rank
ROA 4.04%
ROE 10.92%
ROIC 7.68%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

With a decent Profit Margin value of 3.83%, DEX is doing good in the industry, outperforming 62.86% of the companies in the same industry.
In the last couple of years the Profit Margin of DEX has declined.
DEX has a Operating Margin (7.13%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DEX has declined.
With a Gross Margin value of 39.27%, DEX perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
DEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.13%
PM (TTM) 3.83%
GM 39.27%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DEX is creating some value.
DEX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, DEX has an improved debt to assets ratio.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

DEX has an Altman-Z score of 1.96. This is not the best score and indicates that DEX is in the grey zone with still only limited risk for bankruptcy at the moment.
DEX has a Altman-Z score of 1.96. This is comparable to the rest of the industry: DEX outperforms 45.71% of its industry peers.
DEX has a debt to FCF ratio of 4.55. This is a neutral value as DEX would need 4.55 years to pay back of all of its debts.
DEX has a better Debt to FCF ratio (4.55) than 71.43% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that DEX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.38, DEX is in line with its industry, outperforming 54.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.55
Altman-Z 1.96
ROIC/WACC1.19
WACC6.45%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

DEX has a Current Ratio of 1.12. This is a normal value and indicates that DEX is financially healthy and should not expect problems in meeting its short term obligations.
DEX has a worse Current ratio (1.12) than 71.43% of its industry peers.
DEX has a Quick Ratio of 1.12. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.81, DEX perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.81
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.20%.
The Earnings Per Share has been growing by 16.38% on average over the past years. This is quite good.
Looking at the last year, DEX shows a quite strong growth in Revenue. The Revenue has grown by 12.85% in the last year.
The Revenue has been growing by 31.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-44.2%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-954.7%
Revenue 1Y (TTM)12.85%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%-0.87%

3.2 Future

The Earnings Per Share is expected to grow by 8.44% on average over the next years. This is quite good.
Based on estimates for the next years, DEX will show a small growth in Revenue. The Revenue will grow by 2.91% on average per year.
EPS Next Y17.06%
EPS Next 2Y12.08%
EPS Next 3Y8.44%
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y2.23%
Revenue Next 3Y2.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.18, the valuation of DEX can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of DEX indicates a somewhat cheap valuation: DEX is cheaper than 74.29% of the companies listed in the same industry.
DEX is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.25 indicates a rather cheap valuation of DEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DEX indicates a rather cheap valuation: DEX is cheaper than 85.71% of the companies listed in the same industry.
DEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.18
Fwd PE 6.25
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DEX is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
77.14% of the companies in the same industry are more expensive than DEX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.87
EV/EBITDA 3.74
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y12.08%
EPS Next 3Y8.44%

0

5. Dividend

5.1 Amount

No dividends for DEX!.
Industry RankSector Rank
Dividend Yield N/A

DEXELANCE SPA

BIT:DEX (8/6/2025, 7:00:00 PM)

6.72

+0.1 (+1.51%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.93%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap180.97M
Analysts88.57
Price Target11.49 (70.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.59%
PT rev (3m)-14.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.99%
Revenue NY rev (3m)-3.99%
Valuation
Industry RankSector Rank
PE 10.18
Fwd PE 6.25
P/S 0.38
P/FCF 8.87
P/OCF 7.15
P/B 1.08
P/tB N/A
EV/EBITDA 3.74
EPS(TTM)0.66
EY9.82%
EPS(NY)1.07
Fwd EY15.99%
FCF(TTM)0.76
FCFY11.27%
OCF(TTM)0.94
OCFY13.98%
SpS17.72
BVpS6.21
TBVpS-2.46
PEG (NY)0.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.04%
ROE 10.92%
ROCE 10.57%
ROIC 7.68%
ROICexc 8.82%
ROICexgc 52.73%
OM 7.13%
PM (TTM) 3.83%
GM 39.27%
FCFM 4.27%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.55
Debt/EBITDA 1.11
Cap/Depr 21.25%
Cap/Sales 1.03%
Interest Coverage 250
Cash Conversion 44.3%
Profit Quality 111.6%
Current Ratio 1.12
Quick Ratio 0.81
Altman-Z 1.96
F-Score7
WACC6.45%
ROIC/WACC1.19
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.2%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-954.7%
EPS Next Y17.06%
EPS Next 2Y12.08%
EPS Next 3Y8.44%
EPS Next 5YN/A
Revenue 1Y (TTM)12.85%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%-0.87%
Revenue Next Year0.79%
Revenue Next 2Y2.23%
Revenue Next 3Y2.91%
Revenue Next 5YN/A
EBIT growth 1Y-22.63%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year47.8%
EBIT Next 3Y13.65%
EBIT Next 5YN/A
FCF growth 1Y157.29%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y97.69%
OCF growth 3Y11.3%
OCF growth 5YN/A